Procyon Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PCYN research report →
Price Chart
About the company
Procyon Corporation, along with its affiliated entities, specializes in the development and distribution of proprietary medical solutions. Their primary focus is on addressing various skin conditions, including pressure and stasis ulcers, general wounds, dermatitis, inflammation, and other dermatological issues, predominantly within the United States. The company offers a diverse array of products.
- CEO
- Justice W. Anderson
- IPO
- 1996
- Employees
- 19
- HQ
- Oldsmar, FL, US
Get TickerSpark's AI analysis on PCYN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.46M
- P/E
- 78.26
- PEG
- -0.43
- P/S
- 0.22
- P/B
- 0.63
- EV/EBITDA
- 5.47
- Div Yield
- 0.00%
- Gross Margin
- 31.86%
- Op Margin
- -6.69%
- Net Margin
- 0.51%
- ROE
- 1.47%
- ROIC
- -17.53%
Latest fiscal year · YoY change
- Revenue
- $6.67M+33.9%
- Gross Profit
- $2.13M-45.4%
- Op Income
- $-446,533
- Net Income
- $33.89K+109.9%
- EPS
- $0.00+106.0%
- OCF Growth
- -619.7%
- FCF Growth
- -295.8%
- 52W High
- $0.28
- 52W Low
- $0.12
- 50D MA
- $0.22
- 200D MA
- $0.23
- Beta
- -0.95
- RSI (14)
- 7
- Avg Volume
- 464
No earnings-call transcripts are available for PCYN yet.
- Free Float
- 35.1%
- Shares Outstanding
- 8.12M
- Float Shares
- 2.85M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 31, 24 | SUGGS FRED WILSON JR | other | 12,848 |
| Jul 31, 24 | McComas Steven | other | 5,600 |
| Jul 31, 24 | McCullough Monica | other | 7,200 |
| Jul 31, 24 | Treshler Joseph Raymond | other | 7,440 |
| Jun 25, 24 | SPEER FOUNDATION | sell | 40,000 |
| Jun 26, 24 | SPEER FOUNDATION | sell | 40,000 |
| Jul 31, 23 | SUGGS FRED WILSON JR | other | 25,432 |
| Jul 31, 23 | Treshler Joseph Raymond | other | 8,000 |
| Jul 31, 23 | McCullough Monica | other | 7,200 |
| Jul 31, 23 | McComas Steven | other | 5,600 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PCYN coverage
Recent articles, reports, and earnings notes.
No research on PCYN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PCYN report →